{
  "authors": [
    {
      "author": "Fatemeh Bazvand"
    },
    {
      "author": "Elias Khalili Pour"
    },
    {
      "author": "Golnaz Gharehbaghi"
    },
    {
      "author": "Hooshang Faghihi"
    },
    {
      "author": "Alireza Khodabandeh"
    },
    {
      "author": "Mohammadreza Mehrabi Bahar"
    },
    {
      "author": "Hamid Riazi-Esfahani"
    }
  ],
  "doi": "10.2147/IMCRJ.S258881",
  "publication_date": "2020-07-23",
  "id": "EN110788",
  "url": "https://pubmed.ncbi.nlm.nih.gov/32694921",
  "source": "International medical case reports journal",
  "source_url": "",
  "licence": "CC BY-NC",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "A case report of a preterm infant with a history of hypertension underwent intravitreal injection of aflibercept at the 50-week postmenstrual age because of aggressive posterior retinopathy of prematurity (ROP) in both eyes. Seven days after the intravitreal administration of aflibercept, he has a hypertension crisis and an ischemic stroke. Serial fundoscopies implied complete arrest of vascularization till seven months after receiving treatment."
}